EE200100245A - Uued makroliidsed antibiootikumid - Google Patents

Uued makroliidsed antibiootikumid

Info

Publication number
EE200100245A
EE200100245A EEP200100245A EEP200100245A EE200100245A EE 200100245 A EE200100245 A EE 200100245A EE P200100245 A EEP200100245 A EE P200100245A EE P200100245 A EEP200100245 A EE P200100245A EE 200100245 A EE200100245 A EE 200100245A
Authority
EE
Estonia
Prior art keywords
macrolide antibiotics
new macrolide
new
antibiotics
macrolide
Prior art date
Application number
EEP200100245A
Other languages
English (en)
Estonian (et)
Inventor
Kaneko Takushi
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of EE200100245A publication Critical patent/EE200100245A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
EEP200100245A 1998-11-03 1999-10-18 Uued makroliidsed antibiootikumid EE200100245A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10683698P 1998-11-03 1998-11-03
PCT/IB1999/001701 WO2000026224A2 (fr) 1998-11-03 1999-10-18 Nouveaux antibiotiques macrolide

Publications (1)

Publication Number Publication Date
EE200100245A true EE200100245A (et) 2002-10-15

Family

ID=22313524

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100245A EE200100245A (et) 1998-11-03 1999-10-18 Uued makroliidsed antibiootikumid

Country Status (34)

Country Link
US (3) US20020040007A1 (fr)
EP (1) EP1124837A2 (fr)
JP (1) JP4043191B2 (fr)
KR (1) KR20010083944A (fr)
CN (1) CN1376160A (fr)
AP (1) AP2001002131A0 (fr)
AU (1) AU5995299A (fr)
BG (1) BG105543A (fr)
BR (1) BR9914998A (fr)
CA (1) CA2349338C (fr)
CO (1) CO5140110A1 (fr)
CZ (1) CZ20011512A3 (fr)
EA (1) EA200100396A1 (fr)
EE (1) EE200100245A (fr)
GT (1) GT199900192A (fr)
HK (1) HK1049010A1 (fr)
HR (1) HRP20010306A2 (fr)
HU (1) HUP0104192A3 (fr)
ID (1) ID28286A (fr)
IL (1) IL142628A0 (fr)
IS (1) IS5919A (fr)
MA (1) MA26703A1 (fr)
NO (1) NO20012155L (fr)
OA (1) OA11670A (fr)
PA (1) PA8485101A1 (fr)
PE (1) PE20001289A1 (fr)
PL (1) PL348114A1 (fr)
SK (1) SK5812001A3 (fr)
SV (1) SV1999000188A (fr)
TN (1) TNSN99205A1 (fr)
TR (4) TR200200434T2 (fr)
UY (1) UY25780A1 (fr)
WO (1) WO2000026224A2 (fr)
ZA (1) ZA200103289B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
JP4043191B2 (ja) 1998-11-03 2008-02-06 ファイザー・プロダクツ・インク 新規なマクロライド抗生物質
HUP0105190A3 (en) 1999-01-27 2003-03-28 Pfizer Prod Inc Ketolide antibiotics, medicaments containing them and their use
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
ATE340183T1 (de) 1999-04-16 2006-10-15 Kosan Biosciences Inc Antiinfektiöse makrolidderivate
US6458771B1 (en) 1999-04-16 2002-10-01 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
CN1351608A (zh) 1999-05-24 2002-05-29 辉瑞产品公司 13－甲基红霉素衍生物
EP1114826A3 (fr) * 1999-12-29 2001-10-31 Pfizer Products Inc. Macrolides antibactériennes et prokinétiques
EP1146051A3 (fr) * 2000-04-10 2001-10-31 Pfizer Products Inc. Dérivées de l' érythromycine A
EP1167376B1 (fr) * 2000-06-30 2004-07-14 Pfizer Products Inc. Macrolides antibiotiques
WO2006080954A1 (fr) * 2004-07-28 2006-08-03 Ranbaxy Laboratories Limited Derives de cetolides agents antibacteriens
WO2006046112A2 (fr) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Derives de cetolides utiles comme agents antibacteriens
PT1836211E (pt) 2004-12-21 2010-04-08 Pfizer Prod Inc Macrólidos
US20090130225A1 (en) * 2005-11-23 2009-05-21 Anjan Chakrabarti Macrolides derivatives as antibacterial agents
WO2007060518A2 (fr) * 2005-11-23 2007-05-31 Ranbaxy Laboratories Limited Dérivés de cétolide en tant qu'agents antibactériens
US7801502B2 (en) * 2006-12-18 2010-09-21 Aai Corporation Method for implementing continuous radio frequency (RF) alignment in advanced electronic warfare (EW) signal stimulation systems
US8409628B2 (en) 2010-02-04 2013-04-02 Penguin IP Holdings, Inc. Methods and compositions for oxygenation of skin to treat skin disorders
WO2011123619A2 (fr) 2010-03-31 2011-10-06 Penguin Ip Holdings Inc. Mélanges perméables, procédés et compositions pour la peau
AU2014262127B2 (en) * 2013-05-01 2019-05-02 Neoculi Pty Ltd Methods for treating bacterial infections
RU2537143C1 (ru) * 2013-11-08 2014-12-27 Государственное научное учреждение Ставропольский научно-исследовательский институт животноводства и кормопроизводства РАСХН Препарат для лечения и профилактики мастита у коров
WO2018080072A2 (fr) * 2016-10-27 2018-05-03 한국생명공학연구원 Nouveau composé à base de macrolide, son procédé de production, et composition pharmaceutique destinée à prévenir ou à traiter le paludisme et le contenant à titre de principe actif

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
FR2697524B1 (fr) 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
US5332807A (en) 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
HRP931480B1 (en) * 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
HRP950145A2 (en) * 1995-03-27 1997-08-31 Sour Pliva New compounds of the secomacrolide and secoazalide class and a process for the preparation thereof
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
JP2000509712A (ja) 1996-05-07 2000-08-02 アボツト・ラボラトリーズ ６―ｏ―置換エリスロマイシン及びその製造方法
EE03976B1 (et) 1996-07-05 2003-02-17 Biotica Technology Limited Erütromütsiinid ja nende valmistamise meetod
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
KR100523679B1 (ko) 1996-09-04 2005-10-26 아보트 러보러터리즈 항균 활성을 지닌 6-ｏ-치환된 케톨라이드
HRP960497B1 (en) * 1996-10-28 2003-08-31 Pliva Pharm & Chem Works 9-n-ethenyl derivatives of 9(s)-erythromycylamine
HN1998000074A (es) 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
US6407074B1 (en) * 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
EP0895999A1 (fr) * 1997-08-06 1999-02-10 Pfizer Products Inc. Macrolides antibiotiques substitués C"-4
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
WO1999020639A2 (fr) 1997-10-16 1999-04-29 Pliva, Farmaceutska Industrija ,Dionicko, Drustvo NOUVEAUX 3,6-HEMICETALS APPARTENANT A LA CLASSE DES 9a-AZALIDES
PT941998E (pt) * 1998-03-03 2004-12-31 Pfizer Prod Inc Antibioticos macrolidos do tipo 3,6-cetal
JP4043191B2 (ja) 1998-11-03 2008-02-06 ファイザー・プロダクツ・インク 新規なマクロライド抗生物質
CN1351608A (zh) 1999-05-24 2002-05-29 辉瑞产品公司 13－甲基红霉素衍生物
EP1114826A3 (fr) 1999-12-29 2001-10-31 Pfizer Products Inc. Macrolides antibactériennes et prokinétiques
EP1122261A3 (fr) 2000-01-31 2001-09-26 Pfizer Products Inc. Macrolides antibactériennes à 13 ou 14 chainons
EP1167376B1 (fr) 2000-06-30 2004-07-14 Pfizer Products Inc. Macrolides antibiotiques
WO2003004509A2 (fr) 2001-07-03 2003-01-16 Chiron Corporation Macrolides et cetolides d'erythromycine modifiee c12 a activite antibacterienne

Also Published As

Publication number Publication date
ZA200103289B (en) 2002-08-28
BR9914998A (pt) 2001-07-10
SK5812001A3 (en) 2001-12-03
HRP20010306A2 (en) 2002-06-30
PA8485101A1 (es) 2002-08-26
US20050004047A1 (en) 2005-01-06
WO2000026224A2 (fr) 2000-05-11
GT199900192A (es) 2001-04-26
CN1376160A (zh) 2002-10-23
US6835716B2 (en) 2004-12-28
UY25780A1 (es) 2001-08-27
HK1049010A1 (zh) 2003-04-25
AU5995299A (en) 2000-05-22
KR20010083944A (ko) 2001-09-03
CO5140110A1 (es) 2002-03-22
BG105543A (en) 2001-12-29
HUP0104192A2 (hu) 2002-02-28
OA11670A (en) 2005-01-12
CA2349338A1 (fr) 2000-05-11
EA200100396A1 (ru) 2001-10-22
CA2349338C (fr) 2005-12-06
PE20001289A1 (es) 2000-11-22
ID28286A (id) 2001-05-10
TR200200435T2 (tr) 2002-07-22
SV1999000188A (es) 2000-10-16
NO20012155L (no) 2001-07-02
TR200101241T2 (tr) 2001-09-21
HUP0104192A3 (en) 2003-12-29
TR200200436T2 (tr) 2002-06-21
US20030013665A1 (en) 2003-01-16
MA26703A1 (fr) 2004-12-20
NO20012155D0 (no) 2001-05-02
JP4043191B2 (ja) 2008-02-06
AP2001002131A0 (en) 2001-06-30
WO2000026224A3 (fr) 2000-11-16
IS5919A (is) 2001-04-17
US7071170B2 (en) 2006-07-04
US20020040007A1 (en) 2002-04-04
JP2002528553A (ja) 2002-09-03
IL142628A0 (en) 2002-03-10
CZ20011512A3 (cs) 2001-09-12
EP1124837A2 (fr) 2001-08-22
TNSN99205A1 (fr) 2005-11-10
PL348114A1 (en) 2002-05-06
TR200200434T2 (tr) 2002-09-23

Similar Documents

Publication Publication Date Title
IS5528A (is) Ný makrólíð
ATE322910T1 (de) Neuartige antibiotika
IS5919A (is) Ný makrólíð sýklalyf
DE60124594D1 (de) Makrolidantibiotika
DE69919769D1 (de) 3,6-Ketal-Makrolidantibiotika
ATE256694T1 (de) Ketolid-antibiotika
ATE310742T1 (de) C-4ß-SUBSTITUTIERTE MACROLID-DERIVATE
DE69838651D1 (de) Erythromycinderivate
IS5251A (is) 9-oxím erýþrómýsín afleiður
PT1119430E (pt) Fresa
DE69902762T2 (de) Riser-spannanordnung
NO20010250D0 (no) Nocatiacin-antibiotika
DK1027362T3 (da) 2-halogen-6-O-substituerede ketolidderivater
NO20016200D0 (no) Antibiotika
PT984975E (pt) Derivados de eritromicina multiciclicos
DE29812729U1 (de) Siebrechen
FI971952A0 (fi) Antibiotiskt aemne
ID26522A (id) Antibiotik turunan steroid
BR1100453A (pt) derivados de eritromicina
SE9902890D0 (sv) Golvrelaterat arrangemang
UA3149S (uk) Печиво